EndoSound: Bringing Endoscopic Ultrasound to ASCs скачать в хорошем качестве

EndoSound: Bringing Endoscopic Ultrasound to ASCs

Endoscopic ultrasound (EUS) delivers “inside-out” imaging for GI diagnosis and intervention—but legacy systems are costly and concentrated in hospitals. EndoSound enables EUS on the standard scopes GI doctors already own, pairing an over-the-scope transducer with a compact console to bring hospital-grade imaging into ambulatory surgery centers (ASCs). In this live Kingscrowd Capital session, Founder & CMO Dr. Stephen Steinberg and CCO Josh Cohn explain how the platform works, where it adds clinical value (pancreas, biliary, submucosal lesions), and how economics pencil out for ASCs—including the single-use ultrasound adapter and Medicare transitional pass-through. We also cover traction, ASC management agreements, Gen-2 improvements and regulatory strategy (letter-to-file), and why KingsCrowd Capital invested. Speakers: • Dr. Stephen Steinberg — Founder & CMO (Chief Medical Officer), EndoSound • Josh Cohn — Co-Founder & CCO, EndoSound • Chris Lustrino — Founder & CEO, KingsCrowd (Host) • Teddy Lyons — Sr. Investment Associate, KingsCrowd Capital (Analyst view) Chapters 02:32 Meet EndoSound: founders & origin story 06:32 How the tech works + imaging quality & price 11:50 Why ASCs: efficiency, safety, patient experience 14:11 EUS 101: “inside-out” imaging & clinical use cases 17:15 Business model: single-use adapter & pass-through 19:26 Scaling & Gen-2 roadmap (letter-to-file strategy) 23:16 Per-site volumes & recurring revenue drivers 24:48 ASC management agreements & rollout 26:18 Hospital use cases & adoption path 30:15 Why KingsCrowd Capital invested 35:33 Q&A: regulatory path for new versions 36:48 Q&A: differences vs. legacy $400K+ systems 39:12 Q&A: physician feedback & learning curve 42:02 Vision: access, global impact, and AI assist 47:33 Q&A: payer coverage & reimbursement flow 50:27 Wrap-up Disclaimer This video is for educational purposes only and does not constitute investment advice or an offer to buy/sell securities. Always do your own research.